In 2012, Jennifer Aniston became an investor and face of Living Proof; four years later, Unilever agreed to buy the science-based haircare company

In 2012, one of the most photographed women on the planet agreed to co-own a haircare startup few Americans have heard of. It is not a reality show or a perfume line with her face on the label; it is a business built around product development and patents. Four years later, Unilever, the same conglomerate behind Dove and Suave, agreed to buy the whole company up.

It's a curious situation for a culture so used to celebrities "launching" skincare lines with little substantive difference between a white-label and an endorsed product. According to MIT News, Living Proof, the company at the heart of the deal, wasn't dreamed up in a marketing meeting, but grew in the bioengineering lab of MIT professor Robert Langer, a highly prolific scientist. Jennifer Aniston came later, as an investor and face of the company, not its founder.

The lab coat behind "The Rachel"


Living Proof was, in fact, co-founded in 2005 by Langer alongside entrepreneur Jon Flint and venture capitalist Amir Nashat, and built upon an equally strange premise: what if hair products were developed like biotech drugs? A 2016 MIT Technology Review feature on the company's labs found that none of Living Proof's three signature ingredients were the work of beauty chemists looking to create a trendy product.

OFPMA, the brand's "healthy hair molecule," was engineered to cut surface friction on hair and protect it from moisture, reducing frizz and oil. PBAE, the volumizing compound, was originally a material used in Langer's lab to deliver DNA into cells for gene therapy, later adapted to create the illusion of fullness in flat hair by depositing microscopic thickening "dots" on each strand. A third molecule, ETAS, tiny air-filled spheres sprayed onto hair for texture and volume, rounds out the trio; Living Proof held patents on OFPMA and PBAE and had an application pending for ETAS as of that report. This is precisely what makes Aniston's involvement in the company so fascinating. Fortune's 2014 coverage found that by then, the actress was already more of a working partner to the brand, her name put on a line of products built around patents, not packaging.

When a side hustle becomes a billion-dollar category

Unilever announced the deal in December 2016, buying the company outright to fold it into a "Prestige" portfolio that also included Dermalogica, Murad and Kate Somerville. The deal's financial terms were never made public, and Aniston left the brand once it was sold, her shares cashed out in favor of those who had backed it at the time. For Unilever, it was a calculated move to enter the upper mid-market haircare space at a time when drugstore shelves were becoming more crowded and recession-proof than ever.

It's important to note, however, that the success of a single business with a celebrity at its helm does not represent a secret pipeline of stars launching similar biotech-inspired beauty lines under their own names. There are, after all, many companies that function closer to the idea of white-label production and less to a fully realized scientific endeavor. With that said, the case does serve as a helpful corrective to the popular cynicism about the emptiness of celebrity beauty lines.

RResearch in this area suggests that the presence of a recognizable face is not a reliable tool for boosting brand value, but rather the perceived credibility of the endorser. According to a 2026 study titled “Influence of celebrity endorsement on brand equity: the roles of credibility and brand identification,” published in the Journal of Brand Management, it's not the fame that sells a product, but the perceived authority behind it, and the ability to separate a real expert in the field from a hired mark is something that separates customers who can trust a certain brand and those who end up buying into an empty promise.

What this story means for the next celebrity brand you see

For millennials and young consumers who are suspicious of influencer- and celebrity-endorsed beauty products, this story offers a valuable corrective for the way they assess the companies they choose to spend their money on. The questions to ask themselves before clicking the "add to cart" button can't be about the perceived fame of a given personality; they have to be about who is actually behind the label, what they are claiming, and whether they are actually entitled to that claim. Aniston's role at Living Proof appears to have been tied to the company's materials-science story rather than celebrity alone. It's much less glamorous, but it is, in fact, a much more honest reflection of the relationship between a consumer and a product.